Pharmaceutical Technology1h
MSD’s HPV vaccine gains China NMPA’s expanded approval for males
China's National Medical Products Administration has granted expanded approval to MSD's GARDASIL for use in males aged nine to 26 years.
Pharmaceutical Technology5h
Vertex and Orna sign partnership to improve efficiencies of gene therapies
Orna will receive a $65m upfront payment and is eligible to receive potential milestone payments and royalties.
Pharmaceutical Technology3h
Chugai and Araris enter $780m ADC research collaboration
Araris will use its linker technology to generate multi-warhead ADCs for “undisclosed targets” provided by Chugai.
Pharmaceutical Technology5h
EMA gives OMPD to Actuate’s pancreatic cancer therapy
Actuate Therapeutics has gained OMPD from the EMA for elraglusib aimed at treating pancreatic ductal adenocarcinoma (PDAC).
Pharmaceutical Technology8h
FDA awards GSA breakthrough status for relapsed osteosarcoma treatment
GSK has gained US FDA breakthrough therapy designation for GSK'227 to treat adults with relapsed or refractory osteosarcoma.
Pharmaceutical Technology9h
Acelyrin stock plunges after positive Phase II data readout in thyroid eye disease
Acelyrin plans to initiate two Phase III studies this quarter, which will enrol up to 350 patients with thyroid eye disease (TED).